Get started

Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense

Alternate names: Capability Program Executive for Chemical, Biological, Radiological and Nuclear Defense, JPEO for Chemical, Biological, Radiological and Nuclear Defense, Joint Program Executive Office for CBRN Defense, Joint Program Executive Office for Chemical and Biological Defense, Office for Chemical and Biological Defense
ROR: 04qv3a108
OpenAlex ID: I4405272799
Nerve Agents
2007 · Jonathan Newmark · The Neurologist · 98
Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment
2019 · Placide Mbala-Kingebeni, Amuri Aziza, et al. · The Lancet Infectious Diseases · 91
PDF
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial
2017 · May S. ElSherif, Catherine Brown, et al. · Canadian Medical Association Journal · 80
Development, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for human serum samples
2019 · Thomas L. Rudge, Karen A. Sankovich, et al. · PLoS ONE · 56
PDF
Computationally restoring the potency of a clinical antibody against Omicron
2024 · Thomas A. Desautels, Kathryn T. Arrildt, et al. · Nature · 52
2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation
2019 · Placide Mbala-Kingebeni, Catherine B Pratt, et al. · The Lancet Infectious Diseases · 48
PDF
Lassa virus circulating in Liberia: a retrospective genomic characterisation
2019 · Michael R Wiley, Lawrence Fakoli, et al. · The Lancet Infectious Diseases · 42
PDF
Comparison of the performance of an amplicon sequencing assay based on Oxford Nanopore technology to real-time PCR assays for detecting bacterial biodefense pathogens
2020 · Robert Player, Kathleen Verratti, et al. · BMC Genomics · 39
PDF
Multilamellar Vaccine Particle Elicits Potent Immune Activation with Protein Antigens and Protects Mice against Ebola Virus Infection
2019 · Yuchen Fan, Sabrina M. Stronsky, et al. · ACS Nano · 39
Liquid Sulfur Mustard Exposure
2007 · Jonathan Newmark, Janice M. Langer, et al. · Military Medicine · 39
Multilayer thin-film coatings capable of extended programmable drug release: application to human mesenchymal stem cell differentiation
2012 · Jinkee Hong, Luis M. Alvarez, et al. · Drug Delivery and Translational Research · 24
A ribosomal operon database and MegaBLAST settings for strain-level resolution of microbiomes
2022 · Lee J Kerkhof, Pierce A Roth, et al. · FEMS Microbes · 23
Detection and Tracking of a Novel Genetically Tagged Biological Simulant in the Environment
2012 · Peter A. Emanuel, Patricia E. Buckley, et al. · Applied and Environmental Microbiology · 23
Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease
2021 · Nancy A. Niemuth, Dawn Fallacara, et al. · PLoS ONE · 22
PDF
Ebola virus vaccination elicits Ebola virus–specific immune responses without substantial cross-reactivity to other filoviruses
2025 · Thembi Mdluli, Suzanne Wollen-Roberts, et al. · Science Translational Medicine · 21
A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques
2022 · Ronald R. Cobb, Joseph Nkolola, et al. · Med · 20
Approach to Strain Selection and the Propagation of Viral Stocks for Venezuelan Equine Encephalitis Virus Vaccine Efficacy Testing under the Animal Rule
2019 · Janice M. Rusnak, Pamela J. Glass, et al. · Viruses · 18
PDF
Next-generation Diagnostics for Melioidosis: Evaluation of a Prototype i-STAT Cartridge to Detect Burkholderia pseudomallei Biomarkers
2018 · Kevin L Schully, Charles C Young, et al. · Clinical Infectious Diseases · 16
Wastewater Surveillance Pilot at US Military Installations: Cost Model Analysis
2024 · Jaleal S Sanjak, Erin M McAuley, et al. · JMIR Public Health and Surveillance · 15
PDF
Aeromedical Evacuation of Patients with Contagious Infections
2019 · Brian T. Garibaldi, Nicholas G. Conger, et al. · Springer eBooks · 15
PDF
Impact of SARS-CoV-2 Mutations on PCR Assay Sequence Alignment
2022 · Daniel Antonio Negrón, June Kang, et al. · Frontiers in Public Health · 14
Method feasibility for cross-species testing, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for non-human primate serum samples
2020 · Nancy A. Niemuth, Thomas L. Rudge, et al. · PLoS ONE · 12
PDF
Exception to the exception rule: synthetic and naturally occurring single chromosome Vibrio cholerae
2020 · Shanmuga Sozhamannan, Torsten Waldminghaus · Environmental Microbiology · 12
PDF
Assays for the Evaluation of the Immune Response to Marburg and Ebola Sudan Vaccination—Filovirus Animal Nonclinical Group Anti-Marburg Virus Glycoprotein Immunoglobulin G Enzyme-Linked Immunosorbent Assay and a Pseudovirion Neutralization Assay
2022 · Thomas L. Rudge, Nicholas J. Machesky, et al. · Vaccines · 11
PDF
A Survey of Antimicrobial Resistance Determinants in Category A Select Agents, Exempt Strains, and Near-Neighbor Species
2020 · Chris R. Taitt, Tomasz A. Leski, et al. · International Journal of Molecular Sciences · 11
PDF
Works count: 73
Citation count: 3,207
Year
Topic
Type